|
Safety/efficacy of a phase I/II study of SNS-301 added to pembrolizumab in patients with ASPH+ locally advanced unresectable or metastatic/recurrent squamous cell carcinoma of the head and neck (SCCHN). |
|
|
Research Funding - NOCCR/AMR |
|
|
No Relationships to Disclose |
|
|
Leadership - Alvaxa Biosciences (I) |
Stock and Other Ownership Interests - Alvaxa Biosciences; Calithera Biosciences (I); Celgene (I); Five Prime Therapeutics (I); Immunomic Therapeutics; OncoSec; Sensei Biotherapeutics |
Consulting or Advisory Role - Abbvie; Apros Therapeutics (I); Calithera Biosciences; Genexine (I); Ideaya Biosciences (I); IgM Biosciences (I); Immune Design (I); Juno Therapeutics (I); Neoleukin Therapeutics; Nkarta (I); Pulse Biosciences; Seagen (I) |
Research Funding - AstraZeneca/MedImmune (Inst); Exicure (Inst); Immunomic Therapeutics (Inst); Incyte (Inst); Juno Therapeutics (Inst); Minerva Neurosciences (Inst); Pulse Biosciences (Inst); Sensei Biotherapeutics (Inst); X4 Pharma (Inst) |
Travel, Accommodations, Expenses - Immunomic Therapeutics; Immunomic Therapeutics; Pulse Biosciences; Sensei Biotherapeutics |
|
|
Employment - Macrogenics; Sensei Biotherapeutics |
Stock and Other Ownership Interests - Allogene Therapeutics; Inovio Pharmaceuticals; Macrogenics; Merrimack; Sensei Biotherapeutics |
Travel, Accommodations, Expenses - Sensei Biotherapeutics |
|
|
Employment - Inovio Pharmaceuticals; Sensei Biotherapeutics |
Leadership - Sensei Biotherapeutics |
Stock and Other Ownership Interests - Sensei Biotherapeutics |
Consulting or Advisory Role - Sensei Biotherapeutics |
Travel, Accommodations, Expenses - Inovio Pharmaceuticals; Sensei Biotherapeutics |
|
|
Stock and Other Ownership Interests - OncoSec; Valitor |
Consulting or Advisory Role - Array BioPharma; OncoSec; Regeneron; Valitor |
Research Funding - Acerta Pharma (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); Genentech (Inst); Idera (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Oncosec (Inst); OncoSec (Inst); Sensei Biotherapeutics (Inst); Tessa Therapeutics (Inst) |
Travel, Accommodations, Expenses - OncoSec |
(OPTIONAL) Uncompensated Relationships - Merck; Sensei Biotherapeutics |